clopidogrel has been researched along with Kawasaki Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, Y; Ma, Q; Wang, C; Wang, H; Xu, Y; Yu, X | 1 |
| Fu, S; Gao, L; Geng, Z; Gong, F; Wang, H; Wang, W; Wang, Y; Xie, C; Xu, Z; Zhang, Y; Zhou, S | 1 |
| Chen, TT; Guo, YH; Li, Y; Liu, YL; Lu, YH; Shi, K; Wang, XM | 1 |
| Beamish, J; Duff, DF; El Khuffash, A; McMahon, CJ; O'Connell, MJ | 1 |
1 trial(s) available for clopidogrel and Kawasaki Disease
| Article | Year |
|---|---|
[Clinical effect and safety of clopidogrel combined with aspirin in antithrombotic therapy for children with Kawasaki disease complicated by small/medium-sized coronary artery aneurysms].
Topics: Aspirin; Child; Clopidogrel; Coronary Aneurysm; Coronary Vessels; Fibrinolytic Agents; Humans; Mucocutaneous Lymph Node Syndrome | 2019 |
3 other study(ies) available for clopidogrel and Kawasaki Disease
| Article | Year |
|---|---|
Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study.
Topics: Aspirin; Child; Clopidogrel; Coronary Aneurysm; Coronary Thrombosis; Fibrinolytic Agents; Heparin; Humans; Male; Mucocutaneous Lymph Node Syndrome; Quality of Life; Tissue Plasminogen Activator; Warfarin | 2022 |
The safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury.
Topics: Alanine Transaminase; Aspirin; Child; Clopidogrel; Drug Therapy, Combination; Humans; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Retrospective Studies; Treatment Outcome | 2023 |
Calcified occlusion of the right coronary artery in Kawasaki disease: evidence of myocardial ischaemia using cardiac technetium-99m-tetrofosmin perfusion single-photon emission computed tomography.
Topics: Adolescent; Calcification, Physiologic; Clopidogrel; Coronary Vessels; Echocardiography, Stress; Exercise Test; Humans; Male; Mucocutaneous Lymph Node Syndrome; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Platelet Aggregation Inhibitors; Radiopharmaceuticals; Ticlopidine; Tomography, Emission-Computed, Single-Photon; Ventricular Outflow Obstruction | 2006 |